Skip to main content

Ferric Pyrophosphate Citrate use while Breastfeeding

Medically reviewed by Drugs.com. Last updated on Aug 12, 2022.

Drugs containing Ferric Pyrophosphate Citrate: Triferic, Triferic AVNU

Ferric Pyrophosphate Citrate Levels and Effects while Breastfeeding

Summary of Use during Lactation

No information is available on the use of ferric pyrophosphate citrate during breastfeeding and the manufacturer recommends that it not be used during breastfeeding. An alternate intravenous drug with more published data available may be preferred. Holder pasteurization of milk reduces the concentration of iron in milk by about 6.5%.[1]

For additional information on iron use during breastfeeding, see the monograph on Iron Salts.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

References

1.
Mohd-Taufek N, Cartwright D, Davies M, et al. The effect of pasteurization on trace elements in donor breast milk. J Perinatol. 2016;36:897–900. [PubMed: 27253894]

Substance Identification

Substance Name

Ferric Pyrophosphate Citrate

CAS Registry Number

1332-96-3

Drug Class

Breast Feeding

Lactation

Ferric Compounds

Hematinics

Iron Compounds

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.